JWM
SUPN icon

JPL Wealth Management’s Supernus Pharmaceuticals SUPN Stock Holding History

JPL Wealth Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.07K Buy
+40
New +$2.04K ﹤0.01% 960
2025
Q4 		– Sell
-40
Closed -$1.91K – 1002
2025
Q3 		$1.91K Buy
+40
New +$1.61K ﹤0.01% 865

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JPL Wealth Management's SUPN Position: Q1 2026 in Review

JPL Wealth Management opened a new position in Supernus Pharmaceuticals (SUPN) in Q1 2026: 40 shares worth $2.07K. The stake represents ﹤0.01% of the portfolio and ranks #960 among its holdings. This is a return to the name: JPL Wealth Management previously reported a position in SUPN as recently as Q3 2025.

JPL Wealth Management first reported a position in SUPN in Q3 2025 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • JPL Wealth Management held 40 shares of Supernus Pharmaceuticals worth $2.07K as of Q1 2026.
  • Supernus Pharmaceuticals was a new JPL Wealth Management position in Q1 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of JPL Wealth Management's portfolio in Q1 2026, its #960 holding.
  • JPL Wealth Management first reported a position in Supernus Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.